Healthcare Infection Control Practices Advisory Committee (HICPAC), 76589-76590 [2016-26570]
Download as PDF
<![CDATA[
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
OMB Control Number: 3060–XXXX.
Title: Inmate Calling Services Data
Collection; Annual Reporting,
Certification, and Consumer Disclosure
Requirements.
Form Number: FCC Form 2301.
Type of Review: New collection.
Respondents: Business or other forprofit.
Number of Respondents and
Responses: 15 respondents; 15
responses.
Estimated Time per Response: 5
hours–60 hours.
Frequency of Response: Annual
reporting and certification requirements;
third party disclosure requirement.
Obligation To Respond: Mandatory.
Statutory authority for this information
collection is contained in 47 U.S.C. 1,
4(i), 4(j), 201, 225, 276, and 303(r) of the
Communications Act of 1934, as
amended, 47 U.S.C. 151, 154(i)–(j), 201,
225, 276 and 303(r).
Total Annual Burden: 1,200 hours.
Total Annual Cost: No cost.
Privacy Act Impact Assessment: No
impact(s).
Nature and Extent of Confidentiality:
The Commission anticipates providing
confidential treatment for proprietary
information submitted by providers of
inmate calling services (ICS). Parties
that comply with the terms of a
protective order for the proceeding will
have an opportunity to comment on the
data.
Needs and Uses: Section 201 of the
Communications Act of 1934 Act (Act),
as amended, 47 U.S.C. 201, requires that
ICS providers’ rates and practices be just
and reasonable. Section 276 of the Act,
47 U.S.C. 276, requires that payphone
service providers (including those that
serve correctional institutions such as
ICS providers) be fairly compensated.
The Commission’s Second Report and
Order and Third Further Notice of
Proposed Rulemaking (Second Report
and Order), WC Docket No., FCC 15–
136, requires that ICS providers file
annual reports with the Commission,
including certifications that the reported
data are complete and accurate. The
annual reporting and certification rules
require ICS providers to file, among
other things: data regarding their ICS
rates and minutes of use by facility and
size of facility; current ancillary service
charge amounts and the instances of use
of each; and the monthly amount of any
site commission payments. The
Commission also requires an officer of
each ICS provider annually to certify the
accuracy of the data submitted and the
provider’s compliance with the Second
Report and Order. The consumer
disclosure rule requires ICS providers to
inform customers of their rates and
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
charges. The data will assist the
Commission in, among other things,
ensuring compliance with the Second
Report and Order and monitoring the
effectiveness of the ICS reforms adopted
therein. The data will be used to enable
the Commission to assess the costs
related to ICS and ensure that ICS rates
and ancillary service charges related to
ICS rates remain just, reasonable, and
fair, as required by sections 201 and 276
of the Act.
The Commission’s Wireline Bureau
staff will develop a standardized
template for the submission of data and
provide instructions to simplify
compliance with and reduce the
burdens of the data collection. The
template will also include filing
instructions and text fields for
respondents to use to explain portions
of their filings, as needed. See FCC
Form 2301. Providers are encouraged to
file their data electronically via the
Commission’s Electronic Comment
Filing System (ECFS).
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2016–26554 Filed 11–2–16; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID) announces
a meeting of the aforementioned
committee:
Times and Dates:
9:00 a.m.–5:00 p.m., EST, December 1,
2016
9:00 a.m.–12:00 p.m., EST, December
2, 2016
Place: Centers for Disease Control and
Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE., Atlanta, Georgia,
30329; Call-in number: 866–707–0452;
Passcode: 78829617.
Status: Open to the public, in-person
capacity is limited by the space
available and 100 lines on the call-in
number. Time will be available for
public comment. The public is welcome
to submit written comments in advance
of the meeting. Comments should be
submitted in writing by email to the
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
76589
contact person listed below. The
deadline for receipt of written public
comments is November 18, 2016. All
requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length and delivered in 3 minutes or
less. Please note that the public
comment period may end before the
time indicated, following the last call
for comments. Members of the public
who wish to provide public comments
should plan to attend the public
comment session in-person at the start
time listed. Written comments received
in advance of the meeting will be
included in the official record of the
meeting.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include updates on CDC’s activities
for prevention of healthcare associated
infections (HAIs), updates on
antimicrobial stewardship, an update on
infection prevention in long term care
facilities, an update on Draft Infection
Control Guidelines, and an update from
the workgroup for considerations on
endoscope reprocessing.
Agenda items are subject to change as
priorities dictate.
Contact person for More Information:
Erin Stone, M.S., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia 30329.
Telephone (404) 639–4045. Email:
hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\03NON1.SGM
03NON1
76590
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–26570 Filed 11–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17CA]; Docket No. CDC–2016–
0105]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Positive
Health Check Evaluation Trial.’’ CDC is
requesting a three-year approval for a
data collection effort designed to
evaluate effectiveness of the Positive
Health Check (PHC) online tool created
by RTI and CDC. This CDC and
Research Triangle Institute (RTI)
developed tool delivers tailored
evidence based prevention messages to
HIV positive patients, on improving
clinical outcomes and retention in care
of HIV positive patients with
unsuppressed viral loads. This data
collection is also designed to assess the
feasibility of implementing the
intervention in clinics and the cost of
the intervention.
DATES: Written comments must be
received on or before January 3, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0105 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Positive Health Check Evaluation
Trial—New—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
HIV transmission continues to be an
urgent public health challenge in the
United States. According to CDC,
approximately 1.2 million people are
living with HIV, with close to 50,000
new cases each year. Antiretroviral
therapy (ART) suppresses the plasma
HIV viral load (VL) and people living
with HIV (PLWH) who are treated with
ART—compared with those who are
not—have a substantially reduced risk
of transmitting HIV sexually, through
drug sharing, or from mother to child.
However, it is estimated that only 19%
to 28% of people who are infected with
HIV in the United States have an
undetectable HIV VL. To enhance HIV
prevention efforts, implementable,
effective, scalable interventions are
needed that focus on enhancing
prevention and care to improve the
health of and reduce HIV transmission
risk among PLWH. The Positive Health
Check (PHC) intervention is based on
earlier computer-based interventions
that were proven efficacious for HIV
prevention.
The PHC intervention approach is
innovative in multiple ways. First, it
uses an interactive video doctor to
deliver tailored messages that meet
specific patient needs related to
adherence, sexual risk reduction,
engagement in care, mother-to-child
transmission, and drug use. Second, this
intervention is designed specifically to
support patient behavior change by
providing useful tips to practice
between visits. These tips are patient
driven and populated on a handout
while patients use the PHC intervention,
thereby increasing engagement and the
likelihood of success. Third, PHC
supports patient-provider
communication by also generating a set
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Pages 76589-76590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26570]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID) announces a meeting of the aforementioned committee:
Times and Dates:
9:00 a.m.-5:00 p.m., EST, December 1, 2016
9:00 a.m.-12:00 p.m., EST, December 2, 2016
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia, 30329; Call-in number: 866-707-0452; Passcode:
78829617.
Status: Open to the public, in-person capacity is limited by the
space available and 100 lines on the call-in number. Time will be
available for public comment. The public is welcome to submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed below. The deadline for
receipt of written public comments is November 18, 2016. All requests
must contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length and delivered in 3
minutes or less. Please note that the public comment period may end
before the time indicated, following the last call for comments.
Members of the public who wish to provide public comments should plan
to attend the public comment session in-person at the start time
listed. Written comments received in advance of the meeting will be
included in the official record of the meeting.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion, the
Director, National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary, Health and Human Services
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections (HAIs),
updates on antimicrobial stewardship, an update on infection prevention
in long term care facilities, an update on Draft Infection Control
Guidelines, and an update from the workgroup for considerations on
endoscope reprocessing.
Agenda items are subject to change as priorities dictate.
Contact person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30329. Telephone (404) 639-
4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and
[[Page 76590]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-26570 Filed 11-2-16; 8:45 am]
BILLING CODE 4163-18-P
